Trial intelligence / Profile preview

Dasatinib vs imatinib in newly diagnosed chronic-phase Ph+ CML

CTR20131054Phase 3Completed

Sponsor

Bristol Myers Squibb

Start

Apr 2014

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1